This archive report was first published on 22 April 2020.
On April 22, 2020, Oxford University made a significant announcement regarding the COVID-19 pandemic. The university has been working on a potential coronavirus vaccine, and researchers are now set to begin human trials.
The vaccine, known as 'ChAdOX1', has been supported by the Indian Council of Medical Research (ICMR), which referred to it as the frontrunner in the race for a COVID-19 vaccine.
According to the UK government, the Oxford University vaccine for coronavirus will be tested on up to 510 people aged between 18 and 55 years. A group of 1,112 volunteers have already been selected and processed for the COVID-19 vaccine trials.
UK Health Secretary Matt Hancock revealed first-hand information about the potential Oxford University vaccine during a briefing to the UK parliament on how they are bestowing their efforts to develop the first coronavirus vaccine.
The UK government is also funding scientists to help with the trials and offering another fund for the coronavirus vaccine project underway in Imperial College London.
Lead researcher Professor Sarah Gilbert believes that their 'ChAdOx1' vaccine can work against the coronavirus called SARS-CoV-2.
If everything goes well, the team of Oxford University is hoping to produce mass vaccines to everyone by September of this year.
